Yes, but that's a body that's not going to look at the actual drugs or the products and provide independent advice. I am asking, in terms of this whole scheme you've given us of the life cycle approach, where the independent analysis is. Once a product reaches market and there are problems identified, what do you do? Who is doing it?
On January 31st, 2008. See this statement in context.